Merrimack Pharmaceuticals Inc. (MACK) Gained 8.04% or 0.54 To Price $7.24 On Friday

Merrimack Pharmaceuticals Inc. (MACK) gained 8.04% or 0.54 to $7.24. It is nearly 120186 shares traded, which is 170.6% compare to the average total volume 70447. The market cap of MACK is $96.60 million. The year to date change is 73.1%. The 52 week price range is from $3.34 to $10.53. Price of MACK have changed 7.22% during last week. It have changed 12.63% over last month, 61.48% over last 3 months, 18.82% over last 6 months and -35.50% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MACK is 5.59. It is -22.79% below current price. The 200-day Moving Averages for MACK is 5.52. It is -23.76% below current price. The 52-week High is 10.53. It is 45.44% from the current price. The 52-week Low is 3.34. It is -53.87% from current price.

There are some statistics of MACK. It is has market cap $96.60 million. The share outstanding is 13.34 million. The average volume is 70447. The percent of top 15 Institution holding is 54.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MACK is -52.23%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MACK is -39.35%.


Share this post